‹ All Posts
Vimal K

19th Feb 2025 · SEBI-Registered Analyst

Nifty Pharma Techno Funda Analysis

Nifty Pharma may be on spotlight today. We can see a formation of W pattern and a double bottom on the charts and the below stocks in news will be on focus : - Aurobindo Pharma: The USFDA conducted a pre-approval inspection at Eugia Steriles, a 100 per cent subsidiary of Eugia Pharma Specialities and a step down subsidiary of the company, at Anakapalli, Andhra Pradesh, during February 10–18, 2025. The US FDA concluded the inspection with 5 observations, which are procedural in nature. Piramal Pharma: The USFDA conducted a general GMP inspection at the company’s Turbhe facility during February 11–17 and issued a Form 483 with 6 observations. The observations are largely related to the improvement of procedures and practices, and are not related to data integrity.

PPLPHARMA
AUROPHARMA

#WatchOutFor#TechnicalViews#FundamentalViews#StockInNews#EquityResearch
Nifty Pharma.png
262 likes·72 comments